GAFFX
Price
$72.65
Change
-$0.09 (-0.12%)
Updated
May 9 closing price
Net Assets
285.87B
STCZX
Price
$14.82
Change
-$0.05 (-0.34%)
Updated
May 9 closing price
Net Assets
204.85M
Ad is loading...

GAFFX vs STCZX

Header iconGAFFX vs STCZX Comparison
Open Charts GAFFX vs STCZXBanner chart's image
American Funds Growth Fund of Amer F3
Price$72.65
Change-$0.09 (-0.12%)
VolumeN/A
Net Assets285.87B
Virtus Silvant Large-Cap Growth Stk R6
Price$14.82
Change-$0.05 (-0.34%)
VolumeN/A
Net Assets204.85M
GAFFX vs STCZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. STCZX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and STCZX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 286B vs. STCZX (205M). GAFFX pays higher dividends than STCZX: GAFFX (0.70) vs STCZX (0.00). GAFFX was incepted earlier than STCZX: GAFFX (8 years) vs STCZX (11 years). STCZX (0.95) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. STCZX (12.00). GAFFX has a lower initial minimum investment than STCZX: GAFFX (1000000) vs STCZX (2500000). STCZX annual gain was more profitable for investors over the last year : 9.34 vs. GAFFX (3.51). STCZX return over 5 years is better than : 78.94 vs. GAFFX (46.03).
GAFFXSTCZXGAFFX / STCZX
Total Expense Ratio0.300.7242%
Annual Report Gross Expense Ratio0.300.9532%
Fund Existence8 years11 years-
Gain YTD-2.444-5.58744%
Front LoadN/AN/A-
Min. Initial Investment1000000250000040%
Min. Initial Investment IRAN/AN/A-
Net Assets286B205M139,512%
Annual Yield % from dividends0.700.00-
Returns for 1 year3.519.3438%
Returns for 3 years34.0863.7753%
Returns for 5 years46.0378.9458%
Returns for 10 yearsN/A41.75-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
PENN15.640.35
+2.29%
PENN Entertainment
CRL138.79-2.57
-1.82%
Charles River Laboratories International
ACRS1.26-0.05
-3.82%
Aclaris Therapeutics